The in vitro antitumour efficacy of some novel metal complexes of piperazinedithioformates (SR-M) was examined in six cancer cell lines. The activity was compared with that of piperazinedithioformates. Biological evaluations of a series of SR-M compounds suggest that the compounds 1c (SR-Cu) and 1f (SR-Sn) show a potent antitumor activity. The stable conformation structure of SR-Cu as a representative of SR-M was investigated and confirmed by computer workshop.